STOCKHOLM, Sweden, May 3, 2005 (PRIMEZONE) -- Artimplant: On the proposal of the 2004 Nominations Committee the AGM re-elected Akbar Seddigh, Birgit Stattin-Norinder, Ingemar Kihlstrom, Svante Rasmuson and Lennart Ribohn. Akbar Seddigh was appointed Chairman of the Board
Nominations Committee
The AGM decided that representatives for the three largest shareholders on September 30, 2005 shall appoint members to the Nominations Committee for the AGM 2006.
Articles of incorporation
The AGM approved the proposed changes and additions to the articles of incorporation.
Rights issue 1:2 at SEK 4.50
The AGM approved the decision by the Board of Directors to issue one new B-share for each existing A- or B-share, at SEK 4.50 per share.
Employee stock options
The AGM approved the proposed employee stock options programme.
ARTIMPLANT
Artimplant's mission is to develop novel biodegradable materials and implants that meet the needs of patients, physicians and healthcare providers in orthopedics and other therapy areas. The company works together with global partners as a center of excellence in this development.
Artimplant's vision is to become the partner of choice in biomaterials for hard and soft tissue repair in multiple therapy areas.
Artimplant is listed on the Stockholm Exchange, O-list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=94895&fn=wkr0010.pdf